Navigating the challenge of patient selection and scales to measure outcomes in ketamine trials for treatment-resistant depression.
Sarah Pereira Gomes, Sofia Rodrigues Lima, Fabio Gomes de Matos Souza, Luísa Weber Bisol
Journal of psychopharmacology (Oxford, England) 2025 DOI: 10.1177/02698811241276505 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Letter Double-blind Peer reviewed |
|---|---|
| Topics | Ketamine Depression Esketamine |
| Keywords | Scales Ketamine therapy Treatment-resistant depression trd Refractory depression Outcome measures Evaluation metrics Mood disorder treatment Psychiatric research |
| Citations | 1 |
| Key points | The letter identifies methodological concerns in the original study on ketamine for treatment-resistant major depressive disorder. |
Abstract
The letter about the article "Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study" that discusses some points about methodology, outcome measures, and results.